This will be the last monthly roundup for now. Because there are so many publications to cover, we will try moving to a weekly roundup. This will allow us to better highlight the most important [...]
This week we are pleased to have a guest post from Dr. Anna Glezer. She is a perinatal psychiatrist practicing at the University of California San Francisco and the founder of Mind Body Pregnancy, a [...]
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement. Siu AL; US Preventive Services Task Force (USPSTF), Bibbins-Domingo K, et al. JAMA. 2016 Jan 26;315(4):380-7. Is third trimester serotonin reuptake inhibitor use [...]
A new study suggests that a soy-rich diet may improve fertility in women undergoing infertility treatment. How? Researchers hypothesize that soy products may help to offset the the harmful effects of bisphenol A or BPA. [...]
It has been another busy month! Ruta Nonacs, MD PhD Antidepressants, pregnancy, and stigma: how we are failing mothers and babies. Osborne LM, Payne J. J Nerv Ment Dis. 2015 Mar;203(3):164-6. Do anxiety symptoms predict major depressive disorder in midlife [...]
When we started our website 15 years ago, a productive month in the field of reproductive psychiatry meant that a few good articles were published. Times have certainly changed. In fact, it is sometimes difficult [...]
In a recent cross-sectional study from Denmark, researchers compared the prevalence of stress and depressive symptoms among 301 women with recurrent pregnancy loss (or RPL) and 1813 women attempting to conceive naturally. RPL was defined [...]
While many women complain of psychological distress during infertility treatment, it has been somewhat unclear if the anxiety and depression women may experience is related to having to undergo infertility treatment or to the hormonal agents that are used as part of the treatment, or a combination of the two. While we know that changing levels of gonadal hormones, like estrogen, may affect mood and anxiety levels, we have very little information on the psychological effects of the hormone-modulating drugs used in assisted reproductive technology (ART).
Back in 2009, we reported on a study which demonstrated that paroxetine (Paxil) may affect sperm quality in men treated with this antidepressant. A new study reports a similar finding in men treated with sertraline [...]
We are pleased to announce the recent launch of an exciting new research initiative that is being conducted by the Massachusetts General Hospital Center for Women’s Mental Health. The Symptom Tracking in Assisted Reproductive Technologies study (START study) will focus on understanding the risk factors for depressive relapse in women undergoing infertility treatments. There has been a growing request in our clinical work to address the needs of women undergoing infertility treatments. It is our hope that such a study will provide important information on the course and risk of depression in women undergoing fertility treatment and thus inform clinical care.